Chemomab Therapeutics Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $12.8M
Liabilities Breakdown FY2018
Total Liabilities: $3.0M
Asset Breakdown
Total Assets: $12.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.5M | 58.9% |
| Accounts Receivable | $3.4M | 26.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $385.0K | 3.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.5M | 11.4% |
Liabilities Breakdown
Total Liabilities: $3.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $396.0K | 13.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.6M | 86.6% |